Skip to content

Study evaluating the effects of an infant formula on physical growth in healthy term infants

A randomized, controlled, double-blind study to demonstrate that an infant formula supports normal physical growth in healthy term infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22324
Enrollment
Unknown
Registered
2021-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy infants

Interventions

Intervention group: cow’s milk-based nutritionally complete infant formula. Control group: commercially available cow’s milk-based nutritionally complete infant formula.
Foods and nutrients

Sponsors

Danone Nutricia Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy, singleton, term born infants with gestational age of 37 – 42 weeks. 2. Infants aged = 14 days at enrollment. 3. Birth weight within 10th to 90th percentile per gestational age and sex, according to Intergrowth Standards. 4. Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study. 5. Written informed consent (IC) from parent(s) and/or legal guardian(s) aged =18 years at screening.

Exclusion criteria

Exclusion criteria: 1. Infants known or suspected to have cow's milk allergy, fish protein allergy, soy allergy and/or lactose intolerance. 2. Infants with current or previous illnesses/conditions which could interfere with the study outcomes, as assessed by the investigator. 3. Infants with previous, current or intended participation in any other clinical study involving investigational or marketed products.

Design outcomes

Primary

MeasureTime frame
The primary outcome is weight gain (grams per day) [Time frame: enrollment to 16 weeks of intervention]

Secondary

MeasureTime frame
1. Weight [Time frame: enrollment to 16 weeks of intervention] Weight gain in grams/ day 2. Length [Time frame: enrollment to 16 weeks of intervention] Length gain in cm/ day 3. Head circumference [Time frame: enrollment to 16 weeks of intervention] Head circumference gain in cm/ day 4. Study product intake [Time frame: enrollment to 16 weeks of intervention] Parent completed diary 5. Gastrointestinal tolerance [Time frame: enrollment to 16 weeks of intervention] Parent completed diary 6. Adverse events [Time frame: enrollment to 16 weeks of intervention] Standard adverse event reporting Other outcomes 1. Infant stool characteristics [Time frame: enrollment to 16 weeks of intervention] Parent completed diary 2. Infant stool microbiota composition and functionality [Time frame: enrollment to 16 weeks of intervention] Stool sampling 3. Study product appreciation questionnaire [Time frame: enrollment to 16 weeks of intervention] Parent completed questionnaire

Countries

United States

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)